Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
Stephen Bagley, Donald M. O’Rourke
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107419-107419
Closed Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen, Michael Weller, Eudocia Q. Lee, et al.
Neuro-Oncology (2020) Vol. 22, Iss. 8, pp. 1073-1113
Open Access | Times Cited: 822
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 704
Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson, Nicholas G. Minutolo, Saar Gill, et al.
Cancer Research (2020) Vol. 81, Iss. 5, pp. 1201-1208
Open Access | Times Cited: 492
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi, Roza Motavalli, В. А. Сафонов, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 444
Cell membrane coated-nanoparticles for cancer immunotherapy
Yingping Zeng, Sufen Li, Shufen Zhang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 8, pp. 3233-3254
Open Access | Times Cited: 133
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
Darel Martínez Bedoya, Valérie Dutoit, Denis Migliorini
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
Alaa Alnefaie, Sarah Albogami, Yousif A. Asiri, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 72
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Stephen Bagley, Zev A. Binder, Lamia Lamrani, et al.
Nature Cancer (2024)
Open Access | Times Cited: 62
Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
Hongyu Zheng, Xueqiang Peng, Shuo Yang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 58
Immunotherapy in glioblastoma treatment: Current state and future prospects
Samuel Luca Rocha Pinheiro, Fabian Fellipe Bueno Lemos, Hanna Santos Marques, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 4, pp. 138-159
Open Access | Times Cited: 51
Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast Cancer
Sundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 12, pp. 2409-2421
Open Access | Times Cited: 91
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Negar Hosseinkhani, Afshin Derakhshani, Omid Kooshkaki, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8305-8305
Open Access | Times Cited: 85
CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead
Qingyang Zhang, Jieming Ping, Zirui Huang, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 73
The translational challenges of precision oncology
Oriol Pich, Chris Bailey, Thomas B.K. Watkins, et al.
Cancer Cell (2022) Vol. 40, Iss. 5, pp. 458-478
Open Access | Times Cited: 67
PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages
Yukiko Yamaguchi, Jackson Gibson, Kevin Ou, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004400-e004400
Open Access | Times Cited: 58
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
Chiara Corti, Konstantinos Venetis, Elham Sajjadi, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 6, pp. 593-605
Open Access | Times Cited: 53
Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy
Wen Song, Shujun Song, Jing Kuang, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 15977-15993
Closed Access | Times Cited: 49
The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better
Rui Mao, Wanqing Kong, Yukai He
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer
Omattage Mahasha Perera, Patrick B. Thomas, Gail P. Risbridger, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 503-503
Open Access | Times Cited: 38
Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy
Zhibo Zheng, Siyuan Li, Mohan Liu, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3476-3476
Open Access | Times Cited: 28
A Manganese‐Based Nanodriver Coordinates Tumor Prevention and Suppression through STING Activation in Glioblastoma
Wenyuan Zhang, Liejing Lu, Zheng Zhu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Closed Access | Times Cited: 13
Car T Cells in Solid Tumors: Overcoming Obstacles
Joselyn Rojas, María P. Díaz, Jim Palmar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4170-4170
Open Access | Times Cited: 12
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 589-589
Open Access | Times Cited: 46
CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety
Huali Li, Chao Yang, Huangrong Cheng, et al.
Journal of Cancer (2021) Vol. 12, Iss. 6, pp. 1804-1814
Open Access | Times Cited: 43
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Xiao Wang, Xuejiao Yang, Xiang Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top